The Minds Behind the Mission

3

Caladrix is led by a global team with expertise in neurodegeneration, translational research, clinical drug development and company building. The executive team brings decades of experience in biotech, transporter biology and entrepreneurship across varied industries. The lead clinical investigators and board includes leaders in biomarker discovery, protein clearance mechanisms and FDA sanctioned neuroscience trial methodology.

Founders

Jonas Fischer

CO-FOUNDER & CEO

Dr. Markus Krohn

CO-FOUNDER & CSO

Max Brattig

CO-FOUNDER & CFO

Advisors

Prof. Peter Lansbury

Prof. Henrik Zetterberg

Dr. Manfred Windisch

Dr. Suzanne Hendrix

Prof. Jens Wiltfang

Dr. Janeta Popovici-Muller, PhD

Prof. Scott Ayton, PhD

Dr. Francesco G. Salituro, PhD

Board of Directors

Prof. Peter Lansbury

(Chairman)

Michael Messemer

(Director)

Edward Capel-Cure

(Director)

David Oxley

(Director)